Breaking News Instant updates and real-time market news.

CELH

Celsius Holdings

$3.60

-0.6 (-14.29%)

, PK

Park Hotels & Resorts

$25.32

-0.38 (-1.48%)

19:04
09/12/19
09/12
19:04
09/12/19
19:04

Fly Intel: After Hours Movers

HIGHER: Celsius Holdings (CELH) up 4.2% after disclosing stock purchase by chairman... Park Hotels (PK) up 3.8% after entering S&P MidCap 400 index... ViewRay (VRAY) up 3.4% after announcing collaboration with Stanford Health Care... MDC Holdings (MDC) up 1.5% after QTD Q3 net new order activity rose 63%. DOWN AFTER EARNINGS: Broadcom (AVGO) down 1.4%... Park City Group (PCYG) down 15.0%. ALSO LOWER: Ritter Pharma (RTTR) down 74.9% after its phase 3 trial of RP-G28 fails to demonstrate statistical significance... Energy Recovery (ERII) down 11.5% after filing mixed shelf, selling stock for holders. Movers as of 18:45ET

CELH

Celsius Holdings

$3.60

-0.6 (-14.29%)

PK

Park Hotels & Resorts

$25.32

-0.38 (-1.48%)

VRAY

ViewRay

$3.87

0.085 (2.25%)

MDC

M.D.C. Holdings

$40.33

0.87 (2.20%)

AVGO

Broadcom

$300.68

2.96 (0.99%)

PCYG

Park City Group

$7.82

1.02 (15.00%)

RTTR

Ritter Pharmaceuticals

$1.08

-0.03 (-2.70%)

ERII

Energy Recovery

$10.77

0.22 (2.09%)

  • 12

    Sep

  • 12

    Sep

  • 15

    Sep

  • 16

    Sep

  • 12

    Sep

CELH Celsius Holdings
$3.60

-0.6 (-14.29%)

PK Park Hotels & Resorts
$25.32

-0.38 (-1.48%)

09/12/19
EVER
09/12/19
UPGRADE
EVER
Outperform
Park Hotels & Resorts upgraded to Outperform from In Line at Evercore ISI
09/03/19
WELS
09/03/19
NO CHANGE
WELS
Hurricane Dorian should further mute growth for lodging industry, says Wells Fargo
Noting that the lodging industry was already experiencing a relatively week Q3 to date, Wells Fargo analyst Dori Kesten says that the impact of Hurricane Dorian over Labor Day weekend and now this week should further mute growth. Lodging companies with the largest exposure to these coastal markets, as well as Orlando whose airport closed and Miami which is still expected to experience tropical storm force winds, include Ryman Hospitality Properties (RHP), Hyatt Hotels (H), Xenia Hotels & Resorts (XHR), Park Hotels & Resorts (PK), and Hersha Hospitality (HT), with over 10% of rooms exposed, he notes. Excluding Orlando, the analyst believes those with the greatest exposure would be Hersha Hospitality, RLJ Lodging Trust, and Apple Hospitality REIT (APLE).
09/12/19
EVER
09/12/19
UPGRADE
Target $31
EVER
Outperform
Evercore ISI upgrades 'unjustifiably cheap' Park Hotels to Outperform
As previously reported, Evercore ISI analyst Rich Hightower upgraded Park Hotels & Resorts (PK) to Outperform from In Line following Chesapeake Lodging Trust (CHSP) shareholders' approval of the proposed merger with Park. The rating change "is not necessarily an incrementally bullish call on the lodging cycle overall," but is due to his view that Park Hotels shares have gotten "unjustifiably cheap" when compared to peers since the merger announcement, despite the improvement in portfolio quality that comes along with the acquisition, Hightower tells investors. He trimmed his price target on Park Hotels shares to $31 from $33.
06/25/19
SOCO
06/25/19
INITIATION
Target $34
SOCO
Overweight
Park Hotels & Resorts initiated with an Overweight at Capital One
Capital One initiated Park Hotels & Resorts with an Overweight and $34 price target.
VRAY ViewRay
$3.87

0.085 (2.25%)

08/09/19
CANT
08/09/19
NO CHANGE
Target $6
CANT
Overweight
ViewRay price target lowered to $6 from $13 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou lowered his price target for ViewRay to $6 from $13 saying the "light" orders in Q2 and reduced guidance disappoint. The weak orders, install delays and increased expected cash burn "naturally raise concerns," Bijou tells investors in a research note. That said, the analyst remains positive on ViewRay long term and expects the investment into the business over the past year to drive adoption of the MRIdian.
08/19/19
PIPR
08/19/19
NO CHANGE
PIPR
Overweight
ViewRay prostate cancer study findings 'highly compelling,' says Piper Jaffray
Piper Jaffray analyst Matt O'Brien said he views the results of ViewRay's prostate cancer study as "a highly compelling example of the unique advantages of the MRIdian system" and thinks these results, along with further MRIdian data, should continue to make the selling process for the company easier. The analyst, who expects ViewRay to take market share in upcoming quarters, keeps an Overweight rating on the stock.
08/09/19
JEFF
08/09/19
NO CHANGE
Target $7
JEFF
Buy
ViewRay price target lowered to $7 from $14 at Jefferies
Jefferies analyst Anthony Petrone halved his price target for ViewRay to $7 from $14 saying "all that could go wrong went wrong" in Q2. The company's orders fell short, sales guidance was slashed $30M at the midpoint on slower installs, driving cash burn $15M higher at the midpoint, and it announced the resignation of its CFO in the coming weeks, Petrone tells investors in a research note. The analyst, however, remains positive on the long-term prospects for MRIdian. He keeps a Buy rating on ViewRay.
08/09/19
PIPR
08/09/19
NO CHANGE
Target $6
PIPR
Overweight
Piper 'defending' ViewRay on today's selloff, cuts target to $6 from $15
ViewRay reported Q2 results that beat sales expectations, though "poor" backlog growth and a pushout of five systems into 2020 will lead to weakness in the shares, Piper Jaffray analyst Matt O'Brien tells investors in a research note. While a "little disappointed" to see so few new systems in the order book, the analyst agrees with management that capital sales can be lumpy. He's "defending the name" amid today's selloff because he believes ViewRay's technology value is "significant." This "hiccup" in 2019 could be easily followed by many years of "top-tier growth" given the unique advantages of the MRIdian system, says O'Brien. He cut his price target for the shares to $6 from $15 but reiterates an Overweight rating on ViewRay.
MDC M.D.C. Holdings
$40.33

0.87 (2.20%)

09/21/18
JPMS
09/21/18
DOWNGRADE
Target $32
JPMS
Underweight
M.D.C. Holdings downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Michael Rehaut downgraded M.D.C. Holdings to Underweight and lowered his price target for the shares to $32 from $38. The analyst says the stock, after outperforming year-to-date, does not properly reflect his fundamental outlook for the sector. Further, he believes M.D.C.'s fundamentals will "moderate solidly" in 2019, beginning with Q4 order growth down 6%.
10/25/18
EVER
10/25/18
UPGRADE
EVER
Outperform
M.D.C. Holdings upgraded to Outperform from In Line at Evercore ISI
10/25/18
EVER
10/25/18
UPGRADE
Target $31
EVER
Outperform
M.D.C. Holdings upgraded to Outperform on valuation at Evercore ISI
As previously reported, Evercore ISI upgraded M.D.C. Holdings to Outperform from In Line and trimmed its price target to $31 from $33. Analyst Stephen Kim said the Homebuilders group has sold off sharply and is now trading at a 20% discount to book values, a traditional buy signal.
07/08/19
JPMS
07/08/19
UPGRADE
JPMS
Neutral
M.D.C. Holdings upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Michael Rehaut upgraded M.D.C. Holdings to Neutral from Underweight.
AVGO Broadcom
$300.68

2.96 (0.99%)

08/15/19
DAIW
08/15/19
DOWNGRADE
Target $290
DAIW
Neutral
Broadcom downgraded to Hold from Buy at Daiwa
Daiwa analyst Louis Miscioscia downgraded Broadcom to Hold from Buy and lowered his price target on the stock to $290 from $345.
08/13/19
BOFA
08/13/19
NO CHANGE
Target $103
BOFA
Buy
Crowdstrike price target raised to $103 from $89 at BofA/Merrill
BofA Merrill Lynch analyst Tal Liani noted that he had expected and incorporated some share gains for Crowdstrike (CRWD) from Symantec (SYMC) in his model, but following the recent announcement that Broadcom (AVGO) intends to buy Symantec's enterprise business he sees the potential for those share gains to accelerate. Liani, who raised his price target on Crowdstrike shares to $103 from $89, reiterated a Buy rating on the stock. Aside from the potential for Crowdstrike in antivirus, Liani sees other areas of cyber security where Symantec leads and he could see shares losses should Broadcom's deal create any uncertainty around Symantec's roadmap or commitment to R&D in the space. In email security the beneficiaries would be Proofpoint (PFPT) and Mimecast (MIME) and in secure web gateways the beneficiary could be Zscaler (ZS), Liani noted.
09/09/19
WELS
09/09/19
NO CHANGE
Target $25
WELS
Market Perform
Symantec Consumer Cyber Safety a candidate to be taken private, says Wells Fargo
Wells Fargo analyst Philip Winslow notes that after announcing last month that Broadcom (AVGO) will acquire Symantec's (SYMC) Enterprise Security business, various news outlets reported that Advent International and Permira Holdings are interested in purchasing Symantec's Consumer Cyber Safety business for $26-$27 per share. The analyst believes Symantec's Consumer Cyber Safety business would be a potential candidate to be taken private in a leveraged buyout due given the relative stability of the segment's revenue and cash flow. Winslow reiterates a Market Perform rating and $25 price target on Symantec's shares.
09/09/19
LOOP
09/09/19
NO CHANGE
Target $310
LOOP
Buy
Loop Capital expects cautious Q3 tone, return to growth in Q4 for Broadcom
Loop Capital analyst Cody Acree kept his Buy rating and $310 price target on Broadcom ahead of its Q3 earnings this Thursday. The analyst says that he expects the company to maintain its cautious stance regarding its channel and OEM inventory trends along with expressing concern over the direction of end-market demand as a result of the macro-related uncertainties. Acree still sees Broadcom returning to sequential and annual growth in Q4 as a result of the seasonal ramp of its largest mobile customer and the retaking of socket market share with upcoming models.
PCYG Park City Group
$7.82

1.02 (15.00%)

09/14/18
LOOP
09/14/18
NO CHANGE
Target $15
LOOP
Buy
Park City Group business model manifestation 'exciting', says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $15 price target on Park City Group, saying that while the start to 2018 has been as expected, the set-up for 2019 is becoming more "exciting". The analyst notes that the company can "enter a period of ongoing sequential revenue growth" now that all 3 of its service offerings - Supply Chain, Compliance, and MarketPlace - are running.
02/08/19
LOOP
02/08/19
NO CHANGE
Target $15
LOOP
Buy
Park City Group can enter period of sequential sales growth, says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $15 price target on Park City Group after the company's "very solid" earnings and revenue and "very strong" operating margins. The analyst believes that while the company will continue to experience "revenue seasonality", he also expects it to enter a period of ongoing sequential revenue growth and sees its focus on service offerings generating "attractive returns".
RTTR Ritter Pharmaceuticals
$1.08

-0.03 (-2.70%)

ERII Energy Recovery
$10.77

0.22 (2.09%)

12/07/18
GHSC
12/07/18
DOWNGRADE
GHSC
Neutral
Energy Recovery downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Mike Urban downgraded Energy Recovery to Neutral from Buy citing uncertainty in the oil & gas business. Urban said there is little to no visibility in the timing or path to VorTeq and MTeq commercialization and the revenue and cost model remain unclear.
03/07/19
03/07/19
NO CHANGE

Energy Recovery reports Q4 adjusted EPS 3c, consensus (1c)
Reports Q4 revenue $17.7M, consensus $14.79M.

TODAY'S FREE FLY STORIES

AGFS

AgroFresh Solutions

$2.39

0.125 (5.53%)

16:47
10/14/19
10/14
16:47
10/14/19
16:47
Hot Stocks
AgroFresh awarded $31M in damages in Decco Poast-Harvest lawsuit »

AgroFresh was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$53.12

-2.86 (-5.11%)

16:47
10/14/19
10/14
16:47
10/14/19
16:47
Initiation
eHealth initiated  »

eHealth initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GPN

Global Payments

$164.14

1.2 (0.74%)

16:38
10/14/19
10/14
16:38
10/14/19
16:38
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 31

    Oct

  • 13

    Nov

APTS

Preferred Apartment

$14.41

0.075 (0.52%)

16:36
10/14/19
10/14
16:36
10/14/19
16:36
Hot Stocks
Preferred Apartment names Joel Murphy as CEO, effective January 1, 2020 »

Preferred Apartment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHI

Omega Healthcare

$43.05

0.65 (1.53%)

16:36
10/14/19
10/14
16:36
10/14/19
16:36
Hot Stocks
Omega Healthcare raises quarterly dividend to 67c from 66c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

RPAY

Repay Holdings

$13.21

-0.07 (-0.53%)

16:35
10/14/19
10/14
16:35
10/14/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Repay Holdings »

Repay Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

SQ

Square

$61.83

0.29 (0.47%)

16:34
10/14/19
10/14
16:34
10/14/19
16:34
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

FISV

Fiserv

$106.05

0.41 (0.39%)

, FDC

First Data

$0.00

(0.00%)

16:34
10/14/19
10/14
16:34
10/14/19
16:34
Initiation
Fiserv, First Data initiated  »

Fiserv initiated with a…

FISV

Fiserv

$106.05

0.41 (0.39%)

FDC

First Data

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 27

    Oct

LDOS

Leidos

$82.50

-0.66 (-0.79%)

16:31
10/14/19
10/14
16:31
10/14/19
16:31
Hot Stocks
Leidos awarded $926M TSA screening equipment contract »

Leidos was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 12

    Nov

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

16:30
10/14/19
10/14
16:30
10/14/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Reata Pharmaceuticals »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
10/14/19
10/14
16:30
10/14/19
16:30
Options
Preliminary option volume of 13.7M today »

Preliminary option volume…

FIS

FIS

$132.70

0.69 (0.52%)

16:29
10/14/19
10/14
16:29
10/14/19
16:29
Initiation
FIS initiated  »

FIS initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 19

    Nov

AKRX

Akorn

$3.81

-0.105 (-2.69%)

16:28
10/14/19
10/14
16:28
10/14/19
16:28
Hot Stocks
Akorn gets FDA approval for Betamethasone Dipropionate Lotion, augmented »

Akorn announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

EHTH

eHealth

$53.12

-2.86 (-5.11%)

16:27
10/14/19
10/14
16:27
10/14/19
16:27
Initiation
eHealth initiated  »

eHealth initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GPN

Global Payments

$164.14

1.2 (0.74%)

16:26
10/14/19
10/14
16:26
10/14/19
16:26
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 31

    Oct

  • 13

    Nov

SQ

Square

$61.83

0.29 (0.47%)

16:25
10/14/19
10/14
16:25
10/14/19
16:25
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

FISV

Fiserv

$106.05

0.41 (0.39%)

16:24
10/14/19
10/14
16:24
10/14/19
16:24
Initiation
Fiserv initiated  »

Fiserv initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 27

    Oct

FICO

Fair Isaac

$310.44

0.46 (0.15%)

16:23
10/14/19
10/14
16:23
10/14/19
16:23
Initiation
Fair Isaac initiated  »

Fair Isaac initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:22
10/14/19
10/14
16:22
10/14/19
16:22
General news
Empire State Mfg Survey General Business Conditions Index data reported »

October Empire State Mfg…

PD

PagerDuty

$26.45

0.27 (1.03%)

16:21
10/14/19
10/14
16:21
10/14/19
16:21
Initiation
PagerDuty initiated  »

PagerDuty initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RWT

Redwood Trust

$16.56

-0.1 (-0.60%)

16:20
10/14/19
10/14
16:20
10/14/19
16:20
Hot Stocks
Redwood Trust to acquire CoreVest for approximately $490M »

Redwood Trust announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
10/14/19
10/14
16:20
10/14/19
16:20
Options
Closing CBOE SPX and VIX Index summary for October 14th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$373.02

-1.88 (-0.50%)

, FB

Facebook

$183.29

-0.91 (-0.49%)

16:19
10/14/19
10/14
16:19
10/14/19
16:19
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stock futures fell in…

BA

Boeing

$373.02

-1.88 (-0.50%)

FB

Facebook

$183.29

-0.91 (-0.49%)

PE

Parsley Energy

$15.18

-1.8 (-10.60%)

JAG

Jagged Peak Energy

$6.72

-0.09 (-1.32%)

RVNC

Revance

$14.03

1.86 (15.28%)

HPE

HP Enterprise

$14.94

0.59 (4.11%)

SDC

SmileDirectClub

$9.71

-1.39 (-12.52%)

IPGP

IPG Photonics

$125.41

-10.71 (-7.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 14

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 30

    Oct

  • 06

    Nov

  • 12

    Nov

ACC

American Campus

$48.27

-0.32 (-0.66%)

16:18
10/14/19
10/14
16:18
10/14/19
16:18
Earnings
American Campus raises FY19 FFOM to $2.40-$2.44 from $2.35-$2.45 »

Consensus $2.42. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Nov

BLMN

Bloomin' Brands

$18.14

-0.84 (-4.43%)

16:17
10/14/19
10/14
16:17
10/14/19
16:17
Downgrade
Bloomin' Brands rating change  »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.